Futhan


Indications and Reactions:

Role Indications Reactions
Secondary
Pneumonia 19.4%
Disseminated Intravascular Coagulation 14.1%
Drug Use For Unknown Indication 8.8%
Pancreatitis 8.2%
Urticaria Chronic 7.1%
Cholangitis 5.3%
Allogenic Bone Marrow Transplantation Therapy 4.7%
Pneumonia Bacterial 4.7%
Cerebral Infarction 3.5%
Gastric Ulcer 3.5%
Reflux Oesophagitis 3.5%
Sedation 2.9%
Blood Pressure Increased 2.4%
Colitis Ulcerative 2.4%
Extracorporeal Circulation 2.4%
Polyuria 2.4%
Bacterial Infection 1.8%
Immunosuppression 1.2%
Prophylaxis 1.2%
Hyperparathyroidism Secondary 0.6%
Hepatic Function Abnormal 25.0%
Liver Disorder 22.2%
Sepsis 11.1%
Pancreatitis 8.3%
Jaundice 5.6%
Pyrexia 5.6%
Brain Stem Haemorrhage 2.8%
Cerebral Haemorrhage 2.8%
Eosinophil Count Increased 2.8%
Faeces Discoloured 2.8%
Hepatitis Fulminant 2.8%
Pancreatitis Acute 2.8%
Rash 2.8%
Shock 2.8%
Concomitant
Prophylaxis 19.1%
Sedation 9.0%
Fluid Replacement 7.1%
Infection 7.0%
Interstitial Lung Disease 5.8%
Disseminated Intravascular Coagulation 5.8%
Pyrexia 4.6%
Acute Myeloid Leukaemia Recurrent 4.3%
Drug Use For Unknown Indication 4.2%
Product Used For Unknown Indication 3.9%
Constipation 3.7%
Pancreatitis Acute 3.5%
Ureteral Stent Insertion 3.3%
Ureteral Stent Removal 3.3%
Hypertension 3.1%
Abdominal Pain 2.7%
Diuretic Therapy 2.7%
Sepsis 2.6%
Electrolyte Substitution Therapy 2.1%
Acute Myeloid Leukaemia 2.1%
Respiratory Failure 10.9%
Sepsis 8.9%
Interstitial Lung Disease 6.9%
Platelet Count Decreased 5.9%
Ventricular Failure 5.9%
Weight Increased 5.9%
Blood Bilirubin Increased 5.0%
Thrombocytopenia 5.0%
White Blood Cell Count Decreased 5.0%
White Blood Cell Count Increased 5.0%
Agranulocytosis 4.0%
Decreased Appetite 4.0%
Deep Vein Thrombosis 4.0%
Hepatic Failure 4.0%
Incorrect Route Of Drug Administration 4.0%
Staphylococcal Sepsis 4.0%
Drug Interaction 3.0%
Multi-organ Failure 3.0%
Oxygen Saturation Decreased 3.0%
Pneumonia 3.0%

Drug Data